IBDEI106 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16128,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,16129,0)
 ;;=E05.90^^88^872^41
 ;;^UTILITY(U,$J,358.3,16129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16129,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,16129,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,16129,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,16130,0)
 ;;=E05.91^^88^872^40
 ;;^UTILITY(U,$J,358.3,16130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16130,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,16130,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,16130,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,16131,0)
 ;;=E89.0^^88^872^32
 ;;^UTILITY(U,$J,358.3,16131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16131,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,16131,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,16131,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,16132,0)
 ;;=E03.2^^88^872^13
 ;;^UTILITY(U,$J,358.3,16132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16132,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,16132,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,16132,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,16133,0)
 ;;=E03.9^^88^872^14
 ;;^UTILITY(U,$J,358.3,16133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16133,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16133,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,16133,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,16134,0)
 ;;=E06.0^^88^872^36
 ;;^UTILITY(U,$J,358.3,16134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16134,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,16134,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,16134,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,16135,0)
 ;;=E06.1^^88^872^37
 ;;^UTILITY(U,$J,358.3,16135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16135,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,16135,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,16135,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,16136,0)
 ;;=C73.^^88^872^19
 ;;^UTILITY(U,$J,358.3,16136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16136,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,16136,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,16136,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,16137,0)
 ;;=E16.2^^88^872^10
 ;;^UTILITY(U,$J,358.3,16137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16137,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,16137,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,16137,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,16138,0)
 ;;=E20.0^^88^872^15
 ;;^UTILITY(U,$J,358.3,16138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16138,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,16138,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,16138,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,16139,0)
 ;;=E20.9^^88^872^11
 ;;^UTILITY(U,$J,358.3,16139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16139,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16139,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,16139,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,16140,0)
 ;;=E23.0^^88^872^12
 ;;^UTILITY(U,$J,358.3,16140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16140,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,16140,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,16140,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,16141,0)
 ;;=E27.1^^88^872^34
 ;;^UTILITY(U,$J,358.3,16141,1,0)
 ;;=^358.31IA^4^2
